[ad_1] (RxWiki News) If you have been following the news during the COVID-19 pandemic, you might have noticed that the FDA has been granting “emergency use authorizations” (EUAs) to vaccines
Flying to US: Negative COVID-19 Test Required
[ad_1] (RxWiki News) Traveling to the United States just got a little trickier. The Centers for Disease Control and Prevention (CDC) recently announced that all air passengers who hope to
New Dietary Guidelines: What You Need to Know
[ad_1] (RxWiki News) United States health officials have released new dietary guidelines for 2020 to 2025. Here is what you need to know. Every five years, the US Department of
Generic for Common Hypoglycemia Rx Approved
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a generic version of an injected drug used to treat very low blood sugar. The FDA approved the
How to Use Hand Sanitizer Safely
[ad_1] (RxWiki News) At the start of the COVID-19 pandemic, hand sanitizer was flying off of the shelves. Now, it’s a little easier to get your hands on, but are
Another At-Home COVID-19 Test Gets Green Light
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for an at-home COVID-19 test. The FDA authorized the BinaxNOW COVID-19 Ag Card
New Biosimilar Approved for Multiple Conditions
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new biosimilar to Rituxan (rituximab) to treat several serious conditions. Riabni (rituximab-arrx) is the third approved biosimilar
Dry Skin in Winter? Here’s What to Do
[ad_1] (RxWiki News) As you start to be able to see your breath in the outside air, you may also start to see some dryness and cracking on your skin.
Approved: New Prostate Cancer Rx
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new oral hormone therapy for advanced prostate cancer. The FDA approved Orgovyx (relugolix) to treat adults who
A New Treatment for Non-Small Cell Lung Cancer
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new treatment for non-small cell lung cancer (NSCLC). The FDA approved Tagrisso (osimertinib) to be used alongside
 
				








